Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Revista Médica La Paz
versión On-line ISSN 1726-8958
Resumen
SANJINEZ ASBUN, Marcia; NISHI, Carlos; LOPEZ BILBAO LA VIEJA, Ignacio y URQUIZO AYALA, Guillermo. PREVALENCE OF NON ALCOHOLIC HEPATIC STEATOSIS IN DIABETIC PATIENTS TYPE 2, WITH OR WITHOUT METABOLIC SYNDROME. Rev. Méd. La Paz [online]. 2017, vol.23, n.1, pp.12-18. ISSN 1726-8958.
Has recently been established to non-alcoholic hepatic steatosis as one component of metabolic syndrome, predictor of the development of type 2 diabetes mellitus. Patients with NAFLD and mild to moderate fibrosis, approximately 13% develop cirrhosis in the course of 4 years. So you know the prevalence of this institution at risk for our country, it would take some conduct diagnostic and therapeutic in a timely manner. Objective: To determine the prevalence of non-alcoholic fatty liver in patients with diabetes mellitus type 2. Methods: Cross-sectional study, prospective, descriptive, observational and analytical, cut that includes 95 patients with an established diagnosis of diabetes mellitus type 2, with or without metabolic syndrome. He was performed in measurement of weight, height, BMI, perimeter of waist, visceral fat and percentage of body fat by impedance measurement and liver ultrasound and basal glycaemia. He was the statistical analysis using the S.P.S.S. for Windows, version 12.0 package. Results: Of the total of 95 patients diabetic type 2 studied, 22% (21) were males and 78% (74) women, between 25 to 74 years, of which 58.9% (56) were carriers of metabolic syndrome according to the ATP III criteria. 26.3% (25) patients had no alterations compatible with fatty liver ultrasound. They presented mild steatosis or grade 1 the 16.8% (16), 48.4% steatosis moderate grade 2, and finally 8.4% (8) with severe steatosis or grade 3. Conclusions: The prevalence of non-alcoholic fatty liver, diagnosed by liver ultrasound in type 2 diabetic patients is 74 percent, which increases the risk of complications in these patients.
Palabras clave : Non-alcoholic hepatic steatosis; diabetes mellitus type 2; metabolic syndrome.